Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy

2022-03-23T12:05:49+00:00March 23rd, 2022|

Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy AML cancer cells CONTACT US Summary This study investigated the efficiency [...]

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

2022-03-23T11:31:15+00:00March 23rd, 2022|

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Survival time CONTACT US Summary This study evaluated the safety and efficacy [...]

Combination of External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients

2022-03-23T10:25:00+00:00March 23rd, 2022|

Combination of External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients Before & after treatment CONTACT US Summary The [...]

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

2022-03-10T15:05:45+00:00March 10th, 2022|

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma Prospective recurrence-free survival CONTACT US Summary This study investigated the clinical utilization [...]

Phase I/II study of Immunotherapy using Tumor Antigen-pulsed Dendritic Cells in patients with Hepatocellular Carcinoma (HCC)

2022-03-10T14:52:54+00:00March 10th, 2022|

Phase I/II study of Immunotherapy using Tumor Antigen-pulsed Dendritic Cells in patients with Hepatocellular Carcinoma (HCC) Clinical response to DC vaccine CONTACT US Summary This study evaluated the safety, [...]

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

2022-02-23T16:08:22+00:00February 23rd, 2022|

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients Percentage of progression vs survival [...]

Phase 1/2 Study of Immunotherapy With Dendritic Cells Pulsed With Autologous Tumor Lysate in Patients With Refractory Bone and Soft Tissue Sarcoma

2022-02-23T16:00:05+00:00February 23rd, 2022|

Phase 1/2 Study of Immunotherapy With Dendritic Cells Pulsed With Autologous Tumor Lysate in Patients With Refractory Bone and Soft Tissue Sarcoma Before and after immunotherapy CONTACT US Summary [...]

Immune response generated with the administration of autologous Dendritic Cells pulsed with an allogenic Tumoral Cell- lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma

2022-02-23T15:32:29+00:00February 23rd, 2022|

Immune response generated with the administration of autologous Dendritic Cells pulsed with an allogenic Tumoral Cell- lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma T cell obtained from CFS [...]

Go to Top